At ITRT we are pioneers in the development of advanced cell therapy medicines.

As international leaders in regulated regenerative medicine, we work with cultured mesenchymal cells (CMC) in therapies supported by scientific evidence and individualized authorization by the AEMPS (Spanish Agency of Medicines and Medical Devices).

We manufacture each personalized cell dose in a GMP cleanroom, adapted to the clinical diagnosis of each patient, and administer it in a hospital environment, under controlled conditions and regulated clinical follow-up.

More than 20 years leading clinical research in advanced cell therapies

Since the first clinical trial with cultured mesenchymal cells in 2002, ITRT has developed a therapeutic model based on evidence, personalization, and regulatory compliance.

Our trajectory reflects a continuous evolution towards safer, more effective, and fully regulated treatments.

Over 1,900 patients treated and 3,250 cell doses administered under controlled clinical conditions.

Experts in regulated and personalized cell therapies

Dr. Robert Soler, MD, PhD

Co-founder and Medical Director

Specialist in biological therapies with cultured mesenchymal cells

License No.: 08-26093

Degree in Medicine and Surgery, Autonomous University of Barcelona
Specialist in Rheumatology
Postgraduate in Sports Traumatology, University Paul Sabatier, Toulouse

Dr. Lluís Orozco, MD, PhD

Co-founder and Scientific Director

Specialist in biological therapies with cultured mesenchymal cells

Orthopedic Surgery and Traumatology

License No.: 08-11337

Degree in Medicine and Surgery, University of Navarra
PhD in Medicine, “cum laude”, Autonomous University of Barcelona
Specialist in Orthopedic Surgery and Traumatology

A medical team committed to innovation and excellence

At ITRT we have a highly specialized medical and technical team, committed to clinical excellence, scientific rigor, and regulatory compliance.

Our professionals lead each stage of the treatment: from the manufacture of the cell-based medicine in a cleanroom to its personalized clinical administration and regulated follow-up.